These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12509816)

  • 1. Parameterized evaluation of macromolecules and lipids in proton MR spectroscopy of brain diseases.
    Seeger U; Klose U; Mader I; Grodd W; Nägele T
    Magn Reson Med; 2003 Jan; 49(1):19-28. PubMed ID: 12509816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward accurate quantification of metabolites, lipids, and macromolecules in HRMAS spectra of human brain tumor biopsies using LCModel.
    Opstad KS; Bell BA; Griffiths JR; Howe FA
    Magn Reson Med; 2008 Nov; 60(5):1237-42. PubMed ID: 18836999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton MR spectroscopy with metabolite-nulling reveals elevated macromolecules in acute multiple sclerosis.
    Mader I; Seeger U; Weissert R; Klose U; Naegele T; Melms A; Grodd W
    Brain; 2001 May; 124(Pt 5):953-61. PubMed ID: 11335697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of simulated short echo time 1H human brain spectra by LCModel and AMARES.
    Kanowski M; Kaufmann J; Braun J; Bernarding J; Tempelmann C
    Magn Reson Med; 2004 May; 51(5):904-12. PubMed ID: 15122672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous mapping of metabolites and individual macromolecular components via ultra-short acquisition delay
    Považan M; Strasser B; Hangel G; Heckova E; Gruber S; Trattnig S; Bogner W
    Magn Reson Med; 2018 Mar; 79(3):1231-1240. PubMed ID: 28643447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
    Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short echo time MR spectroscopy of brain tumors: grading of cerebral gliomas by correlation analysis of normalized spectral amplitudes.
    Weis J; Ring P; Olofsson T; Ortiz-Nieto F; Wikström J
    J Magn Reson Imaging; 2010 Jan; 31(1):39-45. PubMed ID: 20027571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elimination of residual lipid contamination in single volume proton MR spectra of human brain.
    Seeger U; Klose U; Lutz O; Grodd W
    Magn Reson Imaging; 1999 Oct; 17(8):1219-26. PubMed ID: 10499684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo proton MR spectroscopy: the diagnostic possibilities of lipid resonances in brain tumors.
    Gotsis ED; Fountas K; Kapsalaki E; Toulas P; Peristeris G; Papadakis N
    Anticancer Res; 1996; 16(3B):1565-7. PubMed ID: 8694527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative 1H-magnetic resonance spectroscopy of human brain: Influence of composition and parameterization of the basis set in linear combination model-fitting.
    Hofmann L; Slotboom J; Jung B; Maloca P; Boesch C; Kreis R
    Magn Reson Med; 2002 Sep; 48(3):440-53. PubMed ID: 12210908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy.
    Howe FA; Barton SJ; Cudlip SA; Stubbs M; Saunders DE; Murphy M; Wilkins P; Opstad KS; Doyle VL; McLean MA; Bell BA; Griffiths JR
    Magn Reson Med; 2003 Feb; 49(2):223-32. PubMed ID: 12541241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved analysis of 1H-MR spectra in the presence of mobile lipids.
    Auer DP; Gössl C; Schirmer T; Czisch M
    Magn Reson Med; 2001 Sep; 46(3):615-8. PubMed ID: 11550257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid and macromolecules quantitation in differentiating glioblastoma from solitary metastasis: a short-echo time single-voxel magnetic resonance spectroscopy study at 3 T.
    Crisi G; Orsingher L; Filice S
    J Comput Assist Tomogr; 2013; 37(2):265-71. PubMed ID: 23493217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton MR spectroscopy in multiple sclerosis: value in establishing diagnosis, monitoring progression, and evaluating therapy.
    Richards TL
    AJR Am J Roentgenol; 1991 Nov; 157(5):1073-8. PubMed ID: 1927795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human brain tumors: assessment with in vivo proton MR spectroscopy.
    Ott D; Hennig J; Ernst T
    Radiology; 1993 Mar; 186(3):745-52. PubMed ID: 8430183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T
    Murali-Manohar S; Borbath T; Wright AM; Soher B; Mekle R; Henning A
    Magn Reson Med; 2020 Aug; 84(2):542-558. PubMed ID: 32003506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localized in vivo human 1H MRS at very short echo times.
    Zhong K; Ernst T
    Magn Reson Med; 2004 Oct; 52(4):898-901. PubMed ID: 15389966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential of MR spectroscopy for assessment of glioma grading.
    Bulik M; Jancalek R; Vanicek J; Skoch A; Mechl M
    Clin Neurol Neurosurg; 2013 Feb; 115(2):146-53. PubMed ID: 23237636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton magnetic resonance spectroscopy in multiple sclerosis.
    Wolinsky JS; Narayana PA; Fenstermacher MJ
    Neurology; 1990 Nov; 40(11):1764-9. PubMed ID: 2172865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton spectroscopic metabolite signal relaxation times in preterm infants: a prerequisite for quantitative spectroscopy in infant brain.
    Kugel H; Roth B; Pillekamp F; Krüger K; Schulte O; von Gontard A; Benz-Bohm G
    J Magn Reson Imaging; 2003 Jun; 17(6):634-40. PubMed ID: 12766891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.